Rankings
▼
Calendar
CAI FY 2024 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
CAI
Caris Life Sciences, Inc.
$5B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$412M
+34.7% YoY
Gross Profit
$179M
43.4% margin
Operating Income
-$257M
-62.4% margin
Net Income
-$282M
-68.4% margin
EPS (Diluted)
$-2.70
Cash Flow
Operating Cash Flow
-$245M
Free Cash Flow
-$254M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$344M
Total Liabilities
$2.8B
Stockholders' Equity
-$2.5B
Cash & Equivalents
$64M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$412M
$306M
+34.7%
Gross Profit
$179M
$89M
+100.2%
Operating Income
-$257M
-$320M
+19.5%
Net Income
-$282M
-$341M
+17.4%
← FY 2023
All Quarters
Q1 2024 →